KYNTRA BIO, INC. (KYNB) Operating income 2016–2025
KYNTRA BIO, INC. (KYNB) annual operating income history from SEC filings — each fiscal year as reported.
-$45.9MFY2025 · since FY2016: -$50.0M → -$45.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$45.9M | +69.5% |
| FY2024 | -$150.4M | +53.4% |
| FY2023 | -$322.7M | -7.2% |
| FY2022 | -$301.0M | -4.3% |
| FY2021 | -$288.5M | -50.4% |
| FY2020 | -$191.9M | -114.8% |
| FY2019 | -$89.3M | -3.0% |
| FY2018 | -$86.7M | +26.1% |
| FY2017 | -$117.3M | -134.4% |
| FY2016 | -$50.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KYNB financial trends
KYNB RevenueKYNB Net incomeKYNB Net marginKYNB Gross profitKYNB Gross marginKYNB Operating marginKYNB Operating cash flowKYNB Free cash flowKYNB Capital expendituresKYNB Return on equityKYNB Stock buybacksKYNB Dividends paidKYNB Total assetsKYNB Total liabilitiesKYNB Shareholders’ equityKYNB overview →